Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a commercial-stage biopharmaceutical company focused on delivering innovative medicines for patients with rare diseases, today announced that new data on ...
Global pharma major Lupin Limited (Lupin) will present data from its phase 1a clinical trial evaluating LNP3693, a STING agonist, at the ESMO Congress in Berlin, Germany, from October 17 to October 21 ...
14don MSN
This new Gemini trick takes your presentation ideas and instantly brings them to life - here's how
To check this out, sign in to the Gemini website with your Google account. If you have a Pro personal or Workspace account, you should be able to try this new skill right away. If you have a free ...
Visual content depicting climate activists emphasizes emotion and disruption, contrasting with the rational, data-driven ...
In other words, we can use AI as a simulated audience: a stand-in that reacts to a data story as if it were a specific type ...
-- 11 new abstracts including MASH data to be presented at the 76th Annual AASLD The Liver Meeting (R), 7-11 November -- Highlights include data from post-hoc analyses of the ESSENCE trial ...
The randomized, double-blind, placebo-controlled, parallel-group Phase 2a M-ACCEL trial (ClinicalTrials.gov: (NCT05979779) evaluated HU6 at 150 mg, 300 mg, and 450 mg once daily for 26 weeks in adults ...
The right preparation ensures you make the most out of an opportunity to share your story through a fireside chat.
Six honors students and 130 undergraduates will conduct a student-designed exit poll in Charlottesville precincts.
MUMBAI, India and NAPLES, Fla. and BERLIN, Oct. 13, 2025 /PRNewswire/ -- Global pharma major Lupin Limited (Lupin) (BSE: 500257) (NSE: LUPIN) (REUTERS: LUPIN.BO) (BLOOMBERG: LPCIN) will present data ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback